October 29, 2026

3 min watch

NASHVILLE — In this Healio video, Arun B. Jesudian, MD, discusses hepatitis B developments including new therapies for highly selective patients, updated treatment guidelines and different vaccination recommendations from the ACG Annual Meeting.

“The hepatitis B space is changing and, particularly, this might be an inflection point in how we take care of certain patients with hepatitis B,” Jesudian, professor of clinical medicine, director of liver quality and inpatient liver services at Weill Cornell Medicine, told Healio.

Sources/Disclosures

Source:

Healio Interviews

Disclosures:
Jesudian reports no relevant financial disclosures.

Ask a clinical question and tap into Healio AI’s knowledge base.

  • PubMed, enrolling/recruiting trials, guidelines
  • Clinical Guidance, Healio CME, FDA news
  • Healio’s exclusive daily news coverage of clinical data



Source link